Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

The obesity jab may save the food industry’s bacon, but should it?

Semaglutide has reignited the debate over who is responsible for weight, and how as a society we tackle it

The Guardian - UK

The End of Obesity?

The advent of effective new weight loss drugs offers hope for millions of overweight people.

Reason

What is gastric sleeve surgery? New BBC documentary warns of issues with weight-loss surgery

Weight Loss Surgery: Getting Thin Abroad warns of the dangers of cheap options overseas

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Councillor blames 'Greggs diet' for shocking levels of childhood obesity in Northumberland

The Conservative councillor also said there was a constant queue of cars at his local McDonalds

Chronicle Live

Satish Kaushik dies due to heart attack at 66; are obese people more at risk of heart problems?

Actor-Director Satish Kaushik, 66, passed away due to a heart attack in Gurugram early Thursday morning, shared actor and close friend Anpam Kher. As per a report, Anupam confirmed that Satish was at a friend's home in Delhi when he complained of uneasiness.

The Times of India

'Game changer' weight loss drug popular among celebrities is approved for NHS use

The appetite suppressant Wegovy, also known as semaglutide is going to be made available through the NHS and will be supplied via injection to people living with obesity.

Daily Record

'Game changer' weight loss injection to become available on NHS for people with obesity

Health officials have announced that some people will be offered the appetite suppressant Wegovy on prescription, after approval was given for NHS use

Chronicle Live

Read news from The Economist, FT, and more,
with one subscription

Wegovy: Weight loss injection used by celebrities to be made available on NHS

Thousands of people living with obesity to be offered drug that acts as appetite suppressant

Evening Standard

Celebrity weight loss jab to be available on WeightWatchers

WeightWatchers has acquired telehealth provider Sequence that offers users access to drugs used to treat diabetes and obesity under the brand names including Ozempic, Wegovy and Trulicity

The Independent UK

Wegovy: Weight loss injection beloved by celebrities gets green light for NHS

Thousands are expected to be offered the appetite suppressant Wegovy on prescription

The Independent UK

‘Game changer’ weight loss jab to become available on NHS

Experts described the move as a ‘pivotal moment’ for the treatment of people living with obesity.

The Independent UK

WeightWatchers gets into prescription weight loss business

WeightWatchers' stock is soaring after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence

The Independent UK

Gastric bypass surgery helped seven members of this Queensland family lose weight and gain confidence

Seven members of the same Queensland family have had obesity surgery, collectively shedding hundreds of kilograms in weight.

ABC News

Weight management goes digital

Weight Watchers is getting into meds, while digital pharmacies like Ro are moving into obesity.

Axios

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

Salon

The cost of the Ozempic craze

The drug shortage is affecting people with Type 2 diabetes, and a surge in cosmetic use is to blame

WEKU

Diabetes and obesity are on the rise in young adults, a study says

Young Black adults, Mexican Americans and other Hispanic adults experienced the greatest cardiovascular risk factors, according to a study published in the Journal of the American Medical Association.

Tribune News Service

Half of world will be obese by 2035, health organization predicts

Half the world will be overweight by 2035, a health group warns.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

First Thing: Alex Murdaugh found guilty of murder of wife and son

Verdict in case of prominent South Carolina lawyer accused of 2021 double homicide. Plus, scientists discover how whale got voice

Wales Online

Half the world's population predicted to be overweight and obese by 2035 if current trends continue

Survey by the World Obesity Federation makes for grim reading if improvements are not made around the globe

The New Daily

Half the world will be overweight or obese by 2035, slim support for Australians

More than half of the world's population will be overweight or obese by 2035 without significant action, according to a report.

AAP

Few obese Australians receiving targeted GP support

More than two-thirds of Australian adults are classed as overweight or obese and that figure is projected to increase in coming years.

The Guardian - UK

More than half of humans on track to be overweight or obese by 2035 – report

Campaigners urge ambitious global intervention with 25% of people expected to be clinically obese in 12 years

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

Tribune News Service

Eli Lilly is capping consumer insulin costs at $35

Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans.

1 … 55 56 57 58

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Anglia Ruskin University

28 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.